Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Watson, G."" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 71
Tytuł:
Correction: Acipimox in Mitochondrial Myopathy (AIMM): study protocol for a randomised, double-blinded, placebo-controlled, adaptive design trial of the efficacy of acipimox in adult patients with mitochondrial myopathy.
Autorzy:
Abouhajar A; Newcastle Clinical Trials Unit, 1-4 Claremont Terrace, Newcastle University, Newcastle upon Tyne, NE2 4AE, UK.
Alcock L; Brain and Movement Research Group, Clinical Ageing Research Unit, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, NE4 5PL, UK.
Bigirumurame T; Population Health Sciences Institute, Newcastle University, Ridley 1 Building, Newcastle upon Tyne, NE1 7RU, UK.
Bradley P; Pharmacy Directorate, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Freeman Hospital, Freeman Road, Newcastle Upon Tyne, NE7 7DN, UK.
Brown L; Wellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, NE2 4HH, UK.
Campbell I; Pharmacy Directorate, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Freeman Hospital, Freeman Road, Newcastle Upon Tyne, NE7 7DN, UK.
Del Din S; Brain and Movement Research Group, Clinical Ageing Research Unit, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, NE4 5PL, UK.
Faitg J; Wellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, NE2 4HH, UK.
Falkous G; Wellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, NE2 4HH, UK.
Gorman GS; Wellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, NE2 4HH, UK.; NHS Highly Specialised Service for Rare Mitochondrial Disorders, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, NE1 4LP, UK.
Lakey R; Newcastle Clinical Trials Unit, 1-4 Claremont Terrace, Newcastle University, Newcastle upon Tyne, NE2 4AE, UK.
McFarland R; Wellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, NE2 4HH, UK.; NHS Highly Specialised Service for Rare Mitochondrial Disorders, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, NE1 4LP, UK.
Newman J; Wellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, NE2 4HH, UK.
Rochester L; Brain and Movement Research Group, Clinical Ageing Research Unit, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, NE4 5PL, UK.
Ryan V; Population Health Sciences Institute, Newcastle University, Ridley 1 Building, Newcastle upon Tyne, NE1 7RU, UK.
Smith H; Pharmacy Directorate, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Freeman Hospital, Freeman Road, Newcastle Upon Tyne, NE7 7DN, UK.
Steel A; Newcastle Clinical Trials Unit, 1-4 Claremont Terrace, Newcastle University, Newcastle upon Tyne, NE2 4AE, UK.
Stefanetti RJ; Wellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, NE2 4HH, UK.
Su H; Wellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, NE2 4HH, UK.
Taylor RW; Wellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, NE2 4HH, UK.; NHS Highly Specialised Service for Rare Mitochondrial Disorders, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, NE1 4LP, UK.
Thomas NJP; Wellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, NE2 4HH, UK. .; NHS Highly Specialised Service for Rare Mitochondrial Disorders, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, NE1 4LP, UK. .
Tuppen H; Wellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, NE2 4HH, UK.
Vincent AE; Wellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, NE2 4HH, UK.
Warren C; Wellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, NE2 4HH, UK.
Watson G; Newcastle Clinical Trials Unit, 1-4 Claremont Terrace, Newcastle University, Newcastle upon Tyne, NE2 4AE, UK.
Pokaż więcej
Corporate Authors:
AIMM Trial Group:
Źródło:
Trials [Trials] 2022 Oct 05; Vol. 23 (1), pp. 852. Date of Electronic Publication: 2022 Oct 05.
Typ publikacji:
Published Erratum
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Stone disease in low- and middle-income countries: could augmented reality have a role in its management?
Autorzy:
Watson G; East Sussex Hospitals NHS Trust, Eastbourne, UK.; Medi Tech Trust, Eastbourne, UK.
Payne SR; Urolink, British Association of Urological Surgeons, London, UK.
Kunitsky K; UCLA Health, Los Angeles, CA, USA.
Natchagande G; Centre National Hospitalier et Universitaire, Cotonou, Benin.
Mabedi C; Kamuzu Central Hospital, Lilongwe, Malawi.
Scotland KB; UCLA Health, Los Angeles, CA, USA.
Pokaż więcej
Źródło:
BJU international [BJU Int] 2022 Oct; Vol. 130 (4), pp. 400-407. Date of Electronic Publication: 2022 Sep 06.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Augmented Reality*
COVID-19*/epidemiology
Kidney Calculi*/surgery
Lithotripsy*/adverse effects
Urolithiasis*/complications
Urolithiasis*/epidemiology
Urolithiasis*/therapy
Developing Countries ; Humans ; Treatment Outcome ; Ureteroscopy/adverse effects
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Acipimox in Mitochondrial Myopathy (AIMM): study protocol for a randomised, double-blinded, placebo-controlled, adaptive design trial of the efficacy of acipimox in adult patients with mitochondrial myopathy.
Autorzy:
Abouhajar A; Newcastle Clinical Trials Unit, 1-4 Claremont Terrace, Newcastle University, Newcastle upon Tyne, NE2 4AE, UK.
Alcock L; Brain and Movement Research Group, Clinical Ageing Research Unit, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, NE4 5PL, UK.
Bigirumurame T; Population Health Sciences Institute, Newcastle University, Ridley 1 Building, Newcastle upon Tyne, NE1 7RU, UK.
Bradley P; Pharmacy Directorate, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Freeman Hospital, Freeman Road, Newcastle Upon Tyne, NE7 7DN, UK.
Brown L; Wellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, NE2 4HH, UK.
Campbell I; Pharmacy Directorate, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Freeman Hospital, Freeman Road, Newcastle Upon Tyne, NE7 7DN, UK.
Del Din S; Brain and Movement Research Group, Clinical Ageing Research Unit, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, NE4 5PL, UK.
Faitg J; Wellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, NE2 4HH, UK.
Falkous G; Wellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, NE2 4HH, UK.
Gorman GS; Wellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, NE2 4HH, UK.; NHS Highly Specialised Service for Rare Mitochondrial Disorders, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, NE1 4LP, UK.
Lakey R; Newcastle Clinical Trials Unit, 1-4 Claremont Terrace, Newcastle University, Newcastle upon Tyne, NE2 4AE, UK.
McFarland R; Wellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, NE2 4HH, UK.; NHS Highly Specialised Service for Rare Mitochondrial Disorders, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, NE1 4LP, UK.
Newman J; Wellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, NE2 4HH, UK.
Rochester L; Brain and Movement Research Group, Clinical Ageing Research Unit, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, NE4 5PL, UK.
Ryan V; Population Health Sciences Institute, Newcastle University, Ridley 1 Building, Newcastle upon Tyne, NE1 7RU, UK.
Smith H; Pharmacy Directorate, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Freeman Hospital, Freeman Road, Newcastle Upon Tyne, NE7 7DN, UK.
Steel A; Newcastle Clinical Trials Unit, 1-4 Claremont Terrace, Newcastle University, Newcastle upon Tyne, NE2 4AE, UK.
Stefanetti RJ; Wellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, NE2 4HH, UK.
Su H; Wellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, NE2 4HH, UK.
Taylor RW; Wellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, NE2 4HH, UK.; NHS Highly Specialised Service for Rare Mitochondrial Disorders, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, NE1 4LP, UK.
Thomas NJP; Wellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, NE2 4HH, UK. .; NHS Highly Specialised Service for Rare Mitochondrial Disorders, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, NE1 4LP, UK. .
Tuppen H; Wellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, NE2 4HH, UK.
Vincent AE; Wellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, NE2 4HH, UK.
Warren C; Wellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, NE2 4HH, UK.
Watson G; Newcastle Clinical Trials Unit, 1-4 Claremont Terrace, Newcastle University, Newcastle upon Tyne, NE2 4AE, UK.
Pokaż więcej
Corporate Authors:
AIMM Trial Group:
Źródło:
Trials [Trials] 2022 Sep 20; Vol. 23 (1), pp. 789. Date of Electronic Publication: 2022 Sep 20.
Typ publikacji:
Clinical Trial Protocol; Journal Article
MeSH Terms:
Mitochondrial Myopathies*/diagnosis
Mitochondrial Myopathies*/drug therapy
Muscular Diseases*
Adult ; Child ; Humans ; Adenosine Triphosphate ; Aspirin/therapeutic use ; Fatigue ; Pyrazines ; Quality of Life ; Randomized Controlled Trials as Topic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Can ten days of heat acclimation training improve temperate-condition rowing performance in national-level rowers?
Autorzy:
Philp CP; Sport Performance Optimisation Research Team, School of Health Sciences, University of Tasmania, Launceston, Tasmania, Australia.
Pitchford NW; Sport Performance Optimisation Research Team, School of Health Sciences, University of Tasmania, Launceston, Tasmania, Australia.
Visentin DC; Sport Performance Optimisation Research Team, School of Health Sciences, University of Tasmania, Launceston, Tasmania, Australia.
Kitic CM; School of Health, Medical and Applied Sciences, Central Queensland University, Brisbane, Queensland, Australia.
Fell JW; Sport Performance Optimisation Research Team, School of Health Sciences, University of Tasmania, Launceston, Tasmania, Australia.
Buchheit M; French National Institute of Sport (INSEP), Laboratory of Sport, Expertise and Performance (EA 7370), Paris, France.; Institute for Health & Sport, Victoria University, Melbourne, VIC, Australia.; HIIT Science, Revelstoke, BC, Canada.; Kitman Labs, Performance Research Intelligence Initiative, Dublin, Ireland.
Minson CT; Department of Human Physiology, University of Oregon, Eugene, Oregon, United States of America.
Gregory JR; Sports Performance Unit, Tasmanian Institute of Sport, Launceston, Tasmania, Australia.
Watson G; Sport Performance Optimisation Research Team, School of Health Sciences, University of Tasmania, Launceston, Tasmania, Australia.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2022 Sep 01; Vol. 17 (9), pp. e0273909. Date of Electronic Publication: 2022 Sep 01 (Print Publication: 2022).
Typ publikacji:
Journal Article
MeSH Terms:
Hot Temperature*
Water Sports*
Acclimatization ; Adolescent ; Adult ; Ergometry ; Female ; Humans ; Lactates ; Male ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The feasibility of endourological surgery in low-resource settings.
Autorzy:
Watson G; East Sussex Hospitals NHS Trust, Eastbourne, UK.; Medi Tech Trust, Eastbourne, UK.
Niang L; Hôpital Général de Grand Yoff, Dakar, Senegal.
Chandresekhar S; Colombo South Teaching Hospital, Colombo, Sri Lanka.
Natchagande G; Centre National Hospitalier et Universitaire, Cotonou, Benin.
Payne SR; Urolink, British Association of Urological Surgeons, London, UK.
Pokaż więcej
Źródło:
BJU international [BJU Int] 2022 Jul; Vol. 130 (1), pp. 18-25. Date of Electronic Publication: 2022 Jun 03.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Endoscopy*
Prostatic Hyperplasia*
Feasibility Studies ; Humans ; Male
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Necrotising otitis externa antibiotic therapy complications: A retrospective cohort analysis.
Autorzy:
Ijaz A; Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, UK.
Williams E; Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, UK.
Cole J; Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, UK.
Watson G; Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, UK.
Pokaż więcej
Źródło:
Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery [Clin Otolaryngol] 2022 May; Vol. 47 (3), pp. 491-494. Date of Electronic Publication: 2022 Mar 01.
Typ publikacji:
Journal Article
MeSH Terms:
Otitis Externa*/drug therapy
Anti-Bacterial Agents/therapeutic use ; Cohort Studies ; Humans ; Necrosis/drug therapy ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Hot water immersion; potential to improve intermittent running performance and perception of in-game running ability in semi-professional Australian Rules Footballers?
Autorzy:
Philp CP; Sport Performance Optimisation Research Team, School of Health Sciences, University of Tasmania, Launceston, Tasmania, Australia.; Western Bulldogs Football Club, Footscray, Victoria.
Pitchford NW; Sport Performance Optimisation Research Team, School of Health Sciences, University of Tasmania, Launceston, Tasmania, Australia.
Fell JW; Sport Performance Optimisation Research Team, School of Health Sciences, University of Tasmania, Launceston, Tasmania, Australia.
Kitic CM; School of Health, Medical and Applied Sciences, Central Queensland University, Brisbane, Queensland, Australia.
Buchheit M; French National Institute of Sport (INSEP), Laboratory of Sport, Expertise and Performance (EA 7370), Paris, France.; Institute for Health & Sport, Victoria University, Melbourne, Victoria, Australia.; HIITScience, Revelstoke, British Columbia, Canada.; Kitman Labs, Performance Research Intelligence Initiative, Dublin, Ireland.
Petersen AC; Institute for Health & Sport, Victoria University, Melbourne, Victoria, Australia.
Minson CT; Department of Human Physiology, University of Oregon, Eugene, Oregon, United States of America.
Visentin DC; Sport Performance Optimisation Research Team, School of Health Sciences, University of Tasmania, Launceston, Tasmania, Australia.
Watson G; Sport Performance Optimisation Research Team, School of Health Sciences, University of Tasmania, Launceston, Tasmania, Australia.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2022 Feb 16; Vol. 17 (2), pp. e0263752. Date of Electronic Publication: 2022 Feb 16 (Print Publication: 2022).
Typ publikacji:
Journal Article
MeSH Terms:
Body Temperature*
Hot Temperature*
Immersion*
Running*
Athletic Performance/*physiology
Football/*statistics & numerical data
Thermosensing/*physiology
Adult ; Australia ; Exercise ; Humans ; Male ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The influence of exercise intensity and exercise mode on gastrointestinal damage.
Autorzy:
Edwards KH; Sports Performance Optimisation Research Team, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, Tasmania 7250, Australia.; Sports Performance Optimisation Research Team, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, Tasmania 7250, Australia.
Ahuja KD; Sports Performance Optimisation Research Team, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, Tasmania 7250, Australia.; Sports Performance Optimisation Research Team, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, Tasmania 7250, Australia.
Watson G; Sports Performance Optimisation Research Team, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, Tasmania 7250, Australia.; Sports Performance Optimisation Research Team, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, Tasmania 7250, Australia.
Dowling C; Sports Performance Optimisation Research Team, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, Tasmania 7250, Australia.; Sports Performance Optimisation Research Team, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, Tasmania 7250, Australia.
Musgrave H; Sports Performance Optimisation Research Team, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, Tasmania 7250, Australia.; Sports Performance Optimisation Research Team, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, Tasmania 7250, Australia.
Reyes J; Sports Performance Optimisation Research Team, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, Tasmania 7250, Australia.; Sports Performance Optimisation Research Team, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, Tasmania 7250, Australia.
Cherry J; Sports Performance Optimisation Research Team, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, Tasmania 7250, Australia.; Sports Performance Optimisation Research Team, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, Tasmania 7250, Australia.
Kitic CM; Sports Performance Optimisation Research Team, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, Tasmania 7250, Australia.; Sports Performance Optimisation Research Team, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, Tasmania 7250, Australia.
Pokaż więcej
Źródło:
Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme [Appl Physiol Nutr Metab] 2021 Sep; Vol. 46 (9), pp. 1105-1110. Date of Electronic Publication: 2021 Mar 16.
Typ publikacji:
Journal Article; Randomized Controlled Trial
MeSH Terms:
Exercise/*physiology
Gastrointestinal Tract/*physiopathology
Adolescent ; Adult ; Anaerobic Threshold ; Bicycling/physiology ; Cross-Over Studies ; Fatty Acid-Binding Proteins/blood ; Female ; Gastrointestinal Diseases/etiology ; Gastrointestinal Diseases/physiopathology ; Heart Rate ; Humans ; Male ; Oxygen Consumption ; Perception/physiology ; Physical Exertion/physiology ; Running/physiology ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Ru Catalyst Encapsulated into the Pores of MIL-101 MOF: Direct Visualization by TEM.
Autorzy:
Meledina M; Central Facility for Electron Microscopy, RWTH Aachen University, D-52074 Aachen, Germany.; Forschungszentrum Jülich GmbH, Ernst Ruska-Centre (ER-C 2), D-52425 Jülich, Germany.
Watson G; Centre for Ordered Materials, Organometallics and Catalysis (COMOC), Department of Chemistry, Ghent University, Krijgslaan 281-S3, 9000 Ghent, Belgium.
Meledin A; Central Facility for Electron Microscopy, RWTH Aachen University, D-52074 Aachen, Germany.; Forschungszentrum Jülich GmbH, Ernst Ruska-Centre (ER-C 2), D-52425 Jülich, Germany.
Van Der Voort P; Centre for Ordered Materials, Organometallics and Catalysis (COMOC), Department of Chemistry, Ghent University, Krijgslaan 281-S3, 9000 Ghent, Belgium.
Mayer J; Central Facility for Electron Microscopy, RWTH Aachen University, D-52074 Aachen, Germany.; Forschungszentrum Jülich GmbH, Ernst Ruska-Centre (ER-C 2), D-52425 Jülich, Germany.
Leus K; Centre for Ordered Materials, Organometallics and Catalysis (COMOC), Department of Chemistry, Ghent University, Krijgslaan 281-S3, 9000 Ghent, Belgium.
Pokaż więcej
Źródło:
Materials (Basel, Switzerland) [Materials (Basel)] 2021 Aug 12; Vol. 14 (16). Date of Electronic Publication: 2021 Aug 12.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Fucosylated Proteome Profiling Identifies a Fucosylated, Non-Ribosomal, Stress-Responsive Species of Ribosomal Protein S3.
Autorzy:
Watson G; Department of Tumor Biology, Moffitt Cancer Center, Tampa, FL 33602, USA.
Lester D; Department of Tumor Biology, Moffitt Cancer Center, Tampa, FL 33602, USA.
Ren H; Department of Tumor Biology, Moffitt Cancer Center, Tampa, FL 33602, USA.
Forsyth CM; Department of Tumor Biology, Moffitt Cancer Center, Tampa, FL 33602, USA.
Medina E; Department of Drug Discovery, Moffitt Cancer Center, Tampa, FL 33602, USA.
Gonzalez Perez D; Department of Drug Discovery, Moffitt Cancer Center, Tampa, FL 33602, USA.
Darville L; Proteomics and Metabolomics Core, Moffitt Cancer Center, Tampa, FL 33602, USA.
Yao J; Biostatistics and Bioinformatics Shared Resource, Moffitt Cancer Center, Tampa, FL 33602, USA.
Luca V; Department of Drug Discovery, Moffitt Cancer Center, Tampa, FL 33602, USA.
Koomen J; Proteomics and Metabolomics Core, Moffitt Cancer Center, Tampa, FL 33602, USA.; Department of Molecular Oncology, Moffitt Cancer Center, Tampa, FL 33602, USA.
Cen L; Biostatistics and Bioinformatics Shared Resource, Moffitt Cancer Center, Tampa, FL 33602, USA.
Lau E; Department of Tumor Biology, Moffitt Cancer Center, Tampa, FL 33602, USA.
Pokaż więcej
Źródło:
Cells [Cells] 2021 May 25; Vol. 10 (6). Date of Electronic Publication: 2021 May 25.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Neoplasms/*metabolism
RNA/*metabolism
Ribosomal Proteins/*metabolism
Animals ; Cell Line, Tumor ; Glycosylation ; Humans ; Mice ; Mice, Inbred C57BL
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Acute otitis externa: Consensus definition, diagnostic criteria and core outcome set development.
Autorzy:
Smith ME; Cambridge Ear Institute, Cambridge, United Kingdom.
Hardman JC; The Royal Marsden Hospital London, London, United Kingdom.
Mehta N; Royal National ENT Hospital London, London, United Kingdom.
Jones GH; Aintree University Hospitals Liverpool, Liverpool, United Kingdom.
Mandavia R; University College London Hospitals NHS Foundation Trust, London, United Kingdom.
Anderson C; Wexham Park Hospital Slough, Slough, United Kingdom.
Khan M; Manchester University NHS Foundation Trust, Manchester, United Kingdom.
Abdelaziz A; Stockport Medical Group, Stockport, United Kingdom.
Al-Dulaimy B; Wythenshawe Hospital, Wythenshawe, United Kingdom.
Amin N; Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
Anmolsingh R; Wythenshawe Hospital, Wythenshawe, United Kingdom.
Anwar B; Salford Royal Hospital, Salford, United Kingdom.
Bance M; Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
Belfield K; School of Medicine, University of Nottingham, Nottingham, United Kingdom.
Bhutta M; Brighton Sussex University Hospitals, Brighton, United Kingdom.
Buchanan R; Barts Health NHS Trust, London, United Kingdom.
Chandrasekharan D; University College London Hospitals NHS Foundation Trust, London, United Kingdom.
Chu M; Health Education North West, Manchester, United Kingdom.
Chundu S; Anglia Ruskin University, Cambridge, United Kingdom.
Conroy K; Manchester University NHS Foundation Trust, Manchester, United Kingdom.
Crundwell G; Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
Daniel M; Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom.
Daniels J; Tameside and Glossop NHS Integrated Care Trust, Ashton-under-Lyne, United Kingdom.
De S; Alder Hey Children's Hospital NHS Foundation Trust, Liverpool, United Kingdom.
Dobbs S; Health Education North West, Manchester, United Kingdom.
Doshi J; Heartlands Hospital Birmingham, Birmingham, United Kingdom.
Farr M; University of Sheffield, Sheffield, United Kingdom.
Ferdous T; University College London Hospitals NHS Foundation Trust, London, United Kingdom.
Fragkouli E; Oxford University Hospitals Foundation Trust, Oxford, United Kingdom.
Freeman S; Salford Royal Hospital, Salford, United Kingdom.
Ghosh S; Pennine Acute Trust, Manchester, United Kingdom.
Gosnell E; Royal Bolton Hospital, Farnworth, United Kingdom.
Hannan SA; Royal National ENT Hospital London, London, United Kingdom.
Heward E; Manchester University NHS Foundation Trust, Manchester, United Kingdom.
Javed F; Heartlands Hospital Birmingham, Birmingham, United Kingdom.
John D; Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
Nicholls H; Devon General Practice, Exeter, Devon, United Kingdom.
Kasbekar AV; Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom.
Khan H; Manchester University NHS Foundation Trust, Manchester, United Kingdom.
Khan H; Royal Preston Hospital, Fulwood, United Kingdom.
Khwaja S; Manchester University NHS Foundation Trust, Manchester, United Kingdom.
Kotecha B; Nuffield Health Brentwood Hospital, Brentwood, United Kingdom.
Krishnan M; Alder Hey Children's Hospital NHS Foundation Trust, Liverpool, United Kingdom.
Kumar N; Wrightington, Wigan and Leigh NHS Foundation Trust, Wigan, United Kingdom.
Lamb T; Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
Lancer H; Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom.
Manjaly JG; Royal National ENT Hospital London, London, United Kingdom.
Martinez Del Pero M; West Suffolk Hospital, Bury St Edmunds, United Kingdom.
McClenaghan F; Royal National ENT Hospital London, London, United Kingdom.
Milinis K; Alder Hey Children's Hospital NHS Foundation Trust, Liverpool, United Kingdom.
Mistry N; Worcestershire Acute Hospitals NHS Trust, Worcester, United Kingdom.
Mohammed H; Newcastle Upon Tyne University Hospitals NHS Foundation Trust, Newcastle Upon Tyne, United Kingdom.
Morris E; Nuffield Department of Primary Care Health Sciences, United Kingdom.
Morris-Jones S; University College London Hospitals NHS Foundation Trust, London, United Kingdom.
Padee J; University of Manchester, Manchester, United Kingdom.
Pal S; London North West University Healthcare NHS Trust, London, United Kingdom.
Patel S; Aintree University Hospitals Liverpool, Liverpool, United Kingdom.
Pericleous A; West Middlesex University Hospital, Isleworth, United Kingdom.
Qayyum A; North West Anglia NHS Foundation Trust, Peterborough, United Kingdom.
Rouhani M; Imperial College Healthcare NHS Trust, London, United Kingdom.
Saeed H; Manchester University NHS Foundation Trust, Manchester, United Kingdom.
Santhiyapillai M; Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
Seymour K; Barts Health NHS Trust, London, United Kingdom.
Sharma S; Alder Hey Children's Hospital NHS Foundation Trust, Liverpool, United Kingdom.
Siau R; Liverpool University Hospitals NHS Foundation Trust, Liverpool, United Kingdom.
Singh A; London North West University Healthcare NHS Trust, London, United Kingdom.
Stapleton E; Manchester University NHS Foundation Trust, Manchester, United Kingdom.
Stephenson K; Birmingham Children's Hospital, Birmingham, United Kingdom.
Stynes G; Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom.
Subramanian B; Wrightington, Wigan and Leigh NHS Foundation Trust, Wigan, United Kingdom.
Summerfield N; Manchester University NHS Foundation Trust, Manchester, United Kingdom.
Swords C; Ipswich Hospital, Ipswich, United Kingdom.
Trinidade A; Southend University Hospital NHS Foundation Trust, Southend-on-Sea, United Kingdom.
Tse A; Manchester University NHS Foundation Trust, Manchester, United Kingdom.
Twumasi E; Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
Ubhi H; London North West University Healthcare NHS Trust, London, United Kingdom.
Unadkat S; Royal National ENT Hospital London, London, United Kingdom.
Vijendren A; Lister Hospital Stevenage, Stevenage, United Kingdom.
Wasson J; East Kent Hospitals NHS Foundation Trust, Canterbury, United Kingdom.
Watson G; Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom.
Williams G; Grove Park Terrace Surgery, London, United Kingdom.
Wilson J; Newcastle Upon Tyne University Hospitals NHS Foundation Trust, Newcastle Upon Tyne, United Kingdom.
Yao A; Dudley NHS Foundation Trust, Dudley, United Kingdom.
Youssef A; Liverpool University Hospitals NHS Foundation Trust, Liverpool, United Kingdom.
Lloyd SKW; Manchester University NHS Foundation Trust, Manchester, United Kingdom.
Tysome JR; Cambridge Ear Institute, Cambridge, United Kingdom.
Pokaż więcej
Corporate Authors:
INTEGRATE (The UK ENT Trainee Research Network)
Źródło:
PloS one [PLoS One] 2021 May 14; Vol. 16 (5), pp. e0251395. Date of Electronic Publication: 2021 May 14 (Print Publication: 2021).
Typ publikacji:
Journal Article
MeSH Terms:
Ear, External/*pathology
Otitis Externa/*diagnosis
Otitis Externa/*pathology
Pain/*diagnosis
Activities of Daily Living ; Delphi Technique ; Humans ; Otitis Externa/therapy ; Outcome Assessment, Health Care ; Quality of Life ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
A Ru-Complex Tethered to a N-Rich Covalent Triazine Framework for Tandem Aerobic Oxidation-Knoevenagel Condensation Reactions.
Autorzy:
Watson G; Department of Chemistry, Center for Ordered Materials, Organometallics and Catalysis (COMOC), Ghent University, Krijgslaan 281, Building S3 (Campus Sterre), 9000 Gent, Belgium.
Gohari Derakhshandeh P; Department of Chemistry, Center for Ordered Materials, Organometallics and Catalysis (COMOC), Ghent University, Krijgslaan 281, Building S3 (Campus Sterre), 9000 Gent, Belgium.
Abednatanzi S; Department of Chemistry, Center for Ordered Materials, Organometallics and Catalysis (COMOC), Ghent University, Krijgslaan 281, Building S3 (Campus Sterre), 9000 Gent, Belgium.
Schmidt J; Institut für Chemie-Funktionsmaterialien, Technische Universität Berlin, Hardenbergstraße 40, 10623 Berlin, Germany.
Leus K; Department of Chemistry, Center for Ordered Materials, Organometallics and Catalysis (COMOC), Ghent University, Krijgslaan 281, Building S3 (Campus Sterre), 9000 Gent, Belgium.
Van Der Voort P; Department of Chemistry, Center for Ordered Materials, Organometallics and Catalysis (COMOC), Ghent University, Krijgslaan 281, Building S3 (Campus Sterre), 9000 Gent, Belgium.
Pokaż więcej
Źródło:
Molecules (Basel, Switzerland) [Molecules] 2021 Feb 05; Vol. 26 (4). Date of Electronic Publication: 2021 Feb 05.
Typ publikacji:
Journal Article
MeSH Terms:
Coordination Complexes/*chemistry
Ruthenium/*chemistry
Triazines/*chemistry
Aerobiosis ; Catalysis ; Kinetics ; Oxidation-Reduction
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Effects of Activity Tracker Use With Health Professional Support or Telephone Counseling on Maintenance of Physical Activity and Health Outcomes in Older Adults: Randomized Controlled Trial.
Autorzy:
Brickwood KJ; School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, Australia.
Ahuja KDK; School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, Australia.
Watson G; School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, Australia.
O'Brien JA; School of Nursing, College of Health and Medicine, University of Tasmania, Launceston, Australia.
Williams AD; School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, Australia.
Pokaż więcej
Źródło:
JMIR mHealth and uHealth [JMIR Mhealth Uhealth] 2021 Jan 05; Vol. 9 (1), pp. e18686. Date of Electronic Publication: 2021 Jan 05.
Typ publikacji:
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Cell Phone*
Counseling*
Exercise*
Fitness Trackers*
Quality of Life*
Aged ; Aged, 80 and over ; Australia ; Female ; Humans ; Male ; Middle Aged ; Outcome Assessment, Health Care ; Postural Balance
Czasopismo naukowe
Pełny tekstSzczegóły
Tytuł:
Massive inguinoscrotal herniation of the bladder: challenges in non-operative management.
Autorzy:
Adasonla K; Department of Urology, Eastbourne District General Hospital, Eastbourne, UK.
Gabriel J; Department of Urology, Eastbourne District General Hospital, Eastbourne, UK.
Quraishi MK; Department of Urology, Eastbourne District General Hospital, Eastbourne, UK.
Watson G; Department of Urology, Eastbourne District General Hospital, Eastbourne, UK.
Pokaż więcej
Źródło:
Journal of surgical case reports [J Surg Case Rep] 2020 Dec 28; Vol. 2020 (12), pp. rjaa540. Date of Electronic Publication: 2020 Dec 28 (Print Publication: 2020).
Typ publikacji:
Case Reports
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Ibrutinib-based therapy for the treatment of marginal zone lymphoma with central nervous system involvement.
Autorzy:
Furqan F; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Watson G; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Samaniego F; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Fayad LE; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Rashmi Kanagal-Shamanna; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Morrison MW; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Thompson PA; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Steiner RE; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Chi L; Department of Neuro-Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Dabaja B; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Pinnix CC; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Neelapu SS; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Nastoupil LJ; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Strati P; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Pokaż więcej
Źródło:
Leukemia & lymphoma [Leuk Lymphoma] 2020 Dec; Vol. 61 (12), pp. 2980-2984. Date of Electronic Publication: 2020 Jul 10.
Typ publikacji:
Letter; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Lymphoma, B-Cell, Marginal Zone*/diagnosis
Lymphoma, B-Cell, Marginal Zone*/drug therapy
Pyrimidines*/adverse effects
Adenine/analogs & derivatives ; Central Nervous System ; Humans ; Piperidines ; Pyrazoles/adverse effects
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A randomised feasibility study of computerised cognitive training as a therapeutic intervention for people with Huntington's disease (CogTrainHD).
Autorzy:
Yhnell E; Neuroscience and Mental Health Research Institute, Cardiff University (NMHRI), 3rd Floor, Hadyn Ellis Building, Maindy Road, Cardiff, CF24 4HQ UK.; Cardiff University School of Biosciences, The Sir Martin Evans Building, Museum Avenue, Cardiff, CF10 3AX UK.
Furby H; School of Psychology, Cardiff University Brain Research Imaging Centre (CUBRIC), Maindy Road, Cardiff University, Cardiff, CF24 4HQ UK.
Lowe RS; Centre for Trials Research (CTR), Cardiff University, Neuadd Meironnydd, Heath Park, Cardiff, CF14 4YS UK.
Brookes-Howell LC; Centre for Trials Research (CTR), Cardiff University, Neuadd Meironnydd, Heath Park, Cardiff, CF14 4YS UK.
Drew CJG; Centre for Trials Research (CTR), Cardiff University, Neuadd Meironnydd, Heath Park, Cardiff, CF14 4YS UK.
Playle R; Centre for Trials Research (CTR), Cardiff University, Neuadd Meironnydd, Heath Park, Cardiff, CF14 4YS UK.
Watson G; Centre for Trials Research (CTR), Cardiff University, Neuadd Meironnydd, Heath Park, Cardiff, CF14 4YS UK.
Metzler-Baddeley C; School of Psychology, Cardiff University Brain Research Imaging Centre (CUBRIC), Maindy Road, Cardiff University, Cardiff, CF24 4HQ UK.
Rosser AE; Neuroscience and Mental Health Research Institute, Cardiff University (NMHRI), 3rd Floor, Hadyn Ellis Building, Maindy Road, Cardiff, CF24 4HQ UK.; Cardiff University Brain Repair Group, Life Sciences Building, Museum Avenue, Cardiff, CF10 3AX UK.
Busse ME; Centre for Trials Research (CTR), Cardiff University, Neuadd Meironnydd, Heath Park, Cardiff, CF14 4YS UK.
Pokaż więcej
Źródło:
Pilot and feasibility studies [Pilot Feasibility Stud] 2020 Jun 19; Vol. 6, pp. 88. Date of Electronic Publication: 2020 Jun 19 (Print Publication: 2020).
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A review of thirty-nine patients diagnosed with necrotising otitis externa over three years: Is CT imaging for diagnosis sufficient?
Autorzy:
Lau K; Otolaryngology Department, Royal Hallamshire Hospital, Sheffield, UK.
Scotta G; Otolaryngology Department, Royal Hallamshire Hospital, Sheffield, UK.
Wu K; Otolaryngology Department, Royal Hallamshire Hospital, Sheffield, UK.
Kabuli MAK; Radiology Department, Royal Hallamshire Hospital, Sheffield, UK.
Watson G; Otolaryngology Department, Royal Hallamshire Hospital, Sheffield, UK.
Pokaż więcej
Źródło:
Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery [Clin Otolaryngol] 2020 May; Vol. 45 (3), pp. 414-418. Date of Electronic Publication: 2020 Feb 05.
Typ publikacji:
Letter
MeSH Terms:
Tomography, X-Ray Computed*
Otitis Externa/*complications
Otitis Externa/*diagnostic imaging
Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Magnetic Resonance Imaging ; Male ; Middle Aged ; Necrosis ; Otitis Externa/pathology ; Reproducibility of Results ; Retrospective Studies ; Sensitivity and Specificity
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Improvement of alfalfa forage quality and management through the down-regulation of MsFTa1.
Autorzy:
Lorenzo CD; Fundación Instituto Leloir, IIBBA-CONICET, Buenos Aires, Argentina.
García-Gagliardi P; Fundación Instituto Leloir, IIBBA-CONICET, Buenos Aires, Argentina.
Antonietti MS; Fundación Instituto Leloir, IIBBA-CONICET, Buenos Aires, Argentina.
Sánchez-Lamas M; Fundación Instituto Leloir, IIBBA-CONICET, Buenos Aires, Argentina.
Mancini E; Fundación Instituto Leloir, IIBBA-CONICET, Buenos Aires, Argentina.
Dezar CA; Instituto de Agrobiotecnología de Rosario (INDEAR), CONICET, Rosario, Argentina.
Vazquez M; Instituto de Agrobiotecnología de Rosario (INDEAR), CONICET, Rosario, Argentina.
Watson G; Instituto de Agrobiotecnología de Rosario (INDEAR), CONICET, Rosario, Argentina.
Yanovsky MJ; Fundación Instituto Leloir, IIBBA-CONICET, Buenos Aires, Argentina.
Cerdán PD; Fundación Instituto Leloir, IIBBA-CONICET, Buenos Aires, Argentina.; Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Buenos Aires, Argentina.
Pokaż więcej
Źródło:
Plant biotechnology journal [Plant Biotechnol J] 2020 Apr; Vol. 18 (4), pp. 944-954. Date of Electronic Publication: 2019 Oct 13.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Gene Expression Regulation, Plant*
Nutritive Value*
Medicago sativa/*genetics
Plant Proteins/*genetics
Biomass ; Down-Regulation ; Flowers/physiology ; Medicago sativa/chemistry ; Photoperiod
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Isocitrate dehydrogenase 1 mutant glioblastomas demonstrate a decreased rate of pseudoprogression: a multi-institutional experience.
Autorzy:
Mohammadi H; Department of Radiation Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
Shiue K; Department of Radiation Oncology, Indiana University Simon Cancer Center, Indianapolis, USA.
Grass GD; Department of Radiation Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
Verma V; Department of Radiation Oncology, Allegheny General Hospital, Pittsburgh, PA, USA.
Engellandt K; Department of Neurochirurgie and Neuroradiologie, Universitätsklinikum Carl Gustav Carus, Dresden, Germany.
Daubner D; Department of Neurochirurgie and Neuroradiologie, Universitätsklinikum Carl Gustav Carus, Dresden, Germany.
Schackert G; Department of Neurochirurgie and Neuroradiologie, Universitätsklinikum Carl Gustav Carus, Dresden, Germany.
Gondim MJ; Department of Pathology, Indiana University Simon Cancer Center, Indianapolis, USA.
Gondim D; Department of Pathology, Indiana University Simon Cancer Center, Indianapolis, USA.
Vortmeyer AO; Department of Pathology, Indiana University Simon Cancer Center, Indianapolis, USA.
Kamer AP; Department of Radiation Oncology, Indiana University Simon Cancer Center, Indianapolis, USA.
Jin W; Department of Radiation Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
Robinson TJ; Department of Radiation Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
Watson G; Department of Radiation Oncology, Indiana University Simon Cancer Center, Indianapolis, USA.
Yu HM; Department of Radiation Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
Lautenschlaeger T; Department of Radiation Oncology, Indiana University Simon Cancer Center, Indianapolis, USA.
Pokaż więcej
Źródło:
Neuro-oncology practice [Neurooncol Pract] 2020 Mar; Vol. 7 (2), pp. 185-195. Date of Electronic Publication: 2019 Oct 10.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 71

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies